(A chain) Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr Gln Leu Glu Asn Tyr Cys Asn (B chain) Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala Leu Tyr Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Pro Lys Thr (Disulfide bridge: A6-A11, A7-B7, A20-B19)
Insulin human (USP/INN); Insulin human (genetical recombination) (JP18); Insulin human (biosynthesis) (JAN); Insulin human (synthesis) (JAN); Humulin (TN)
(A chain) Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr Gln Leu Glu Asn Tyr Cys Asn (B chain) Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala Leu Tyr Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Pro Lys Thr (Disulfide bridge: A6-A11, A7-B7, A20-B19)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10A INSULINS AND ANALOGUES
A10AB Insulins and analogues for injection, fast-acting
A10AB01 Insulin (human)
D03230 Insulin human (USP/INN) <JP/US>
A10AC Insulins and analogues for injection, intermediate-acting
A10AC01 Insulin (human)
D03230 Insulin human (USP/INN) <JP/US>
A10AD Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting
A10AD01 Insulin (human)
D03230 Insulin human (USP/INN) <JP/US>
A10AE Insulins and analogues for injection, long-acting
A10AE01 Insulin (human)
D03230 Insulin human (USP/INN) <JP/US>
A10AF Insulins and analogues for inhalation
A10AF01 Insulin (human)
D03230 Insulin human (USP/INN) <JP/US>
USP drug classification [BR:br08302]
Blood Glucose Regulators
Insulins
Insulin, Rapid-acting
Insulin Human
D03230 Insulin human (USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
24 Hormones
249 Miscellaneous
2492 Pancreatic hormones
D03230 Insulin human (USP/INN); Insulin human (genetical recombination) (JP18); Insulin human (biosynthesis) (JAN); Insulin human (synthesis) (JAN)
Drug groups [BR:br08330]
Antidiabetic agent
DG01636 Insulin preparation
DG01802 Human insulin
D03230 Insulin human
Metabolizing enzyme inducer
DG01637 CYP1A2 inducer
D03230 Insulin human
Drug classes [BR:br08332]
Antidiabetic agent
DG01636 Insulin preparation
D03230 Insulin human
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
INSR family
INSR (CD220)
D03230 Insulin human (USP/INN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D03230 Insulin human (genetical recombination)
D03230 Insulin human (genetical recombination) injection
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D03230
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D03230
(A chain) Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr Gln Leu Glu Asn Tyr Cys Gly (B chain) Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala Leu Tyr Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Pro Lys Thr Arg Arg (Disulfide bridge: A6-A11, A7-B7, A20-B19)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10A INSULINS AND ANALOGUES
A10AE Insulins and analogues for injection, long-acting
A10AE04 Insulin glargine
D03250 Insulin glargine (USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Blood Glucose Regulators
Insulins
Insulin, Long-acting
Insulin Glargine
D03250 Insulin glargine (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
24 Hormones
249 Miscellaneous
2492 Pancreatic hormones
D03250 Insulin glargine (USAN/INN); Insulin glargine (genetical recombination) (JP18); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 1] (JAN); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 2] (JAN)
Drug groups [BR:br08330]
Antidiabetic agent
DG01636 Insulin preparation
DG01797 Insulin analog, long-acting
D03250 Insulin glargine
Metabolizing enzyme inducer
DG01637 CYP1A2 inducer
D03250 Insulin glargine
Drug classes [BR:br08332]
Antidiabetic agent
DG01636 Insulin preparation
D03250 Insulin glargine
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
INSR family
INSR (CD220)
D03250 Insulin glargine (USAN/INN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D03250 Insulin glargine (genetical recombination)
D03250 Insulin glargine (genetical recombination) injection
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D03250
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D03250
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D03250
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D03250
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D03250
(A chain) Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr Gln Leu Glu Asn Tyr Cys Asn (B chain) Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala Leu Tyr Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Asp Lys Thr (Disulfide bridge: A6-A11, A7-B7, A20-B19)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10A INSULINS AND ANALOGUES
A10AB Insulins and analogues for injection, fast-acting
A10AB05 Insulin aspart
D04475 Insulin aspart (USP/INN) <JP/US>
A10AD Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting
A10AD05 Insulin aspart
D04475 Insulin aspart (USP/INN) <JP/US>
USP drug classification [BR:br08302]
Blood Glucose Regulators
Insulins
Insulin, Rapid-acting
Insulin Aspart
D04475 Insulin aspart (USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
24 Hormones
249 Miscellaneous
2492 Pancreatic hormones
D04475 Insulin aspart (USP/INN); Insulin aspart (genetical recombination) (JP18); Insulin aspart (genetical recombination) [Insulin aspart biosimilar 1] (JAN)
Drug groups [BR:br08330]
Antidiabetic agent
DG01636 Insulin preparation
DG01796 Insulin analog, fast-acting
D04475 Insulin aspart
Metabolizing enzyme inducer
DG01637 CYP1A2 inducer
D04475 Insulin aspart
Drug classes [BR:br08332]
Antidiabetic agent
DG01636 Insulin preparation
D04475 Insulin aspart
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
INSR family
INSR (CD220)
D04475 Insulin aspart (USP/INN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D04475 Insulin aspart (genetical recombination)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D04475
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D04475
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D04475
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D04475
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D04475
(A chain) Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr Gln Leu Glu Asn Tyr Cys Asn (B chain) Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala Leu Tyr Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Lys Pro Thr (Disulfide bridge: A6-A11, A7-B7, A20-B19)
(A chain) Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr Gln Leu Glu Asn Tyr Cys Asn (B chain) Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala Leu Tyr Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Pro Lys-C14H27O (Disulfide bridge: A6-A11, A7-B7, A20-B19)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10A INSULINS AND ANALOGUES
A10AE Insulins and analogues for injection, long-acting
A10AE05 Insulin detemir
D04539 Insulin detemir (USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Blood Glucose Regulators
Insulins
Insulin, Long-acting
Insulin Detemir
D04539 Insulin detemir (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
24 Hormones
249 Miscellaneous
2492 Pancreatic hormones
D04539 Insulin detemir (USAN/INN); Insulin detemir (genetical recombination) (JAN)
Drug groups [BR:br08330]
Antidiabetic agent
DG01636 Insulin preparation
DG01797 Insulin analog, long-acting
D04539 Insulin detemir
Metabolizing enzyme inducer
DG01637 CYP1A2 inducer
D04539 Insulin detemir
Drug classes [BR:br08332]
Antidiabetic agent
DG01636 Insulin preparation
D04539 Insulin detemir
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
INSR family
INSR (CD220)
D04539 Insulin detemir (USAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D04539
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D04539
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D04539
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D04539
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D04539
(A chain) Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr Gln Leu Glu Asn Tyr Cys Asn (B chain) Phe Val Lys Gln His Leu Cys Gly Ser His Leu Val Glu Ala Leu Tyr Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Pro Glu Thr (Disulfide bridge: A6-A11, A7-B7, A20-B19)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10A INSULINS AND ANALOGUES
A10AB Insulins and analogues for injection, fast-acting
A10AB06 Insulin glulisine
D04540 Insulin glulisine (USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Blood Glucose Regulators
Insulins
Insulin, Rapid-acting
Insulin Glulisine, Human
D04540 Insulin glulisine (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
24 Hormones
249 Miscellaneous
2492 Pancreatic hormones
D04540 Insulin glulisine (USAN/INN); Insulin glulisine (genetical recombination) (JAN)
Drug groups [BR:br08330]
Antidiabetic agent
DG01636 Insulin preparation
DG01796 Insulin analog, fast-acting
D04540 Insulin glulisine
Metabolizing enzyme inducer
DG01637 CYP1A2 inducer
D04540 Insulin glulisine
Drug classes [BR:br08332]
Antidiabetic agent
DG01636 Insulin preparation
D04540 Insulin glulisine
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
INSR family
INSR (CD220)
D04540 Insulin glulisine (USAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D04540
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D04540
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D04540
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D04540
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D04540
(A chain) Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala Leu Tyr Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Pro Lys (Amide bridge: 29-C) (B chain) Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr Gln Leu Glu Asn Tyr Cys Asn (Disulfide bridge: 6-11, A7-B7, A19-B20) (C chain)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10A INSULINS AND ANALOGUES
A10AE Insulins and analogues for injection, long-acting
A10AE06 Insulin degludec
D09727 Insulin degludec (USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Blood Glucose Regulators
Insulins
Insulin, Long-acting
Insulin Degludec
D09727 Insulin degludec (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
24 Hormones
249 Miscellaneous
2492 Pancreatic hormones
D09727 Insulin degludec (USAN/INN); Insulin degludec (genetical recombination) (JAN)
Drug groups [BR:br08330]
Antidiabetic agent
DG01636 Insulin preparation
DG01797 Insulin analog, long-acting
D09727 Insulin degludec
Drug classes [BR:br08332]
Antidiabetic agent
DG01636 Insulin preparation
D09727 Insulin degludec
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
INSR family
INSR (CD220)
D09727 Insulin degludec (USAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09727
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D09727
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D09727
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09727